Ernährung bei Lebererkrankungen

 

 Buy Article Permissions and Reprints

Zusammenfassung

Ernährungszustand und Leberkrankheit beeinflussen sich gegenseitig. Leberfunktionen werden durch Mangelernährung beeinträchtigt und können durch Ernährungstherapie wieder verbessert werden. Insbesondere chronische Lebererkrankungen führen abhängig von ihrem klinischen Schweregrad zu einer prognostisch relevanten Mangelernährung. Vorhandensein und Ausmaß der Mangelernährung können klinisch ohne technische Verfahren diagnostiziert werden. Bei schweren akuten Lebererkrankungen unterscheiden sich Indikation und Durchführung der Ernährungstherapie nicht wesentlich von denen aus anderer Ursache kritisch Erkrankter. Bei chronischen Leberkrankheiten ist der spontane Verzehr meist ungenügend und häufig besteht ein Eiweißmangel. In abgestuftem Vorgehen sollten Ernährungsberatung, ergänzende orale Trinknahrungen, enterale Sondennahrung und als Zweitlinientherapie die parenterale Ernährung eingesetzt werden. Die Ernährungstherapie mit Sicherstellung einer adäquaten Versorgung an Energie und Eiweiß kann Morbidität und Überleben verbessern.

Abstract

Nutritional status and liver disease influence each other. Liver function is compromized by malnutrition and this impairment can be overcome by nutritional intervention. Depending on disease severity, especially chronic liver disease leads to malnutrition which is an indicator of a poor prognosis. Both presence and degree of malnutrition can be diagnosed clinically without the need for techniqual equipment. In severe acute liver disease, indication and practice of nutritional therapy are not different from those in critically ill patients due to other etiology. In chronic liver disease, spontaneous food intake often is inadequate and frequently there is protein malnutrition. In a stepwise approach individualized dietary counselling, supplemental oral sip feeding, enteral tube feeding or parenteral nutrition as a second line option should be used. Nutritional therapy ensuring adequate provision of energy and protein can improve morbidity and mortality.

Literatur

• 1 Child C G, Turcotte J G. Surgery and portal hypertension.. In: Child C G The liver and portal hypertension.. Philadelphia: Saunders; 1964: 50-51
  Google Scholar
• 2 Plauth M, Merli M, Kondrup J et al. ESPEN guidelines for nutrition in liver disease and transplantation.  Clin Nutr. 1997;  16 43-55
  PubMedGoogle Scholar
• 3 Selberg O, Böttcher J, Tusch G et al. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients.  Hepatology. 1997;  25 652-657
  CrossrefPubMedGoogle Scholar
• 4 Kondrup J, Müller M J. Energy and protein requirements of patients with chronic liver disease.  J Hepatol. 1997;  27 239-247
  CrossrefPubMedGoogle Scholar
• 5 Plauth M, Schütz T E. Nutrition in Liver Disease.. In: Banerjee, ed Nutritional Management of Digestive Diseases.. Boca Raton: CRC Press; 2010: 271-299
  Google Scholar
• 6 Pirlich M, Schütz T, Spachos T et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites.  Hepatology. 2000;  32 1208-1215
  CrossrefPubMedGoogle Scholar
• 7 Dharancy S, Lemyze M, Boleslawski E et al. Impact of impaired aerobic capacity on liver transplant candidates.  Transplantation. 2008;  86 1077-1083
  CrossrefPubMedGoogle Scholar
• 8 Plauth M. Gastroenterologie und Hepatologie.. In: Löser C Unter- und Mangelernährung.. Stuttgart: Thieme; 2011: 322-332
  Google Scholar
• 9 Peng S, Plank L D, McCall J L et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study.  Am J Clin Nutr. 2007;  85 1257-1266
  PubMedGoogle Scholar
• 10 Laryea M, Watt K D, Molinari M et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.  Liver Transpl. 2007;  13 1109-1114
  CrossrefPubMedGoogle Scholar
• 11 Selberg O, Burchert W, van den Hoff J et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.  J Clin Invest. 1993;  91 1897-1902
  CrossrefPubMedGoogle Scholar
• 12 Schütz T, Bechstein W O, Neuhaus P et al. Clinical practice of nutrition in acute liver failure – a European survey.  Clin Nutr. 2004;  23 975-982
  CrossrefPubMedGoogle Scholar
• 13 Müller M J, Böttcher J, Selberg O et al. Hypermetabolism in clinically stable patients with liver cirrhosis.  Am J Clin Nutr. 1999;  69 1194-1201
  PubMedGoogle Scholar
• 14 Müller M J, Dettmer A, Tettenborn M et al. Metabolic, endocrine, haemodynamic and pulmonary responses to different types of exercise in individuals with normal or reduced liver function.  Eur J Appl Physiol Occup Physiol. 1996;  74 246-257
  CrossrefPubMedGoogle Scholar
• 15 Weimann A, Kuse E R, Bechstein W O et al. Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant units.  Transpl Int. 1998;  11 (S 01) S289-S291
  CrossrefPubMedGoogle Scholar
• 16 Petrides A S, De Fronzo R A. Glucose and insulin metabolism in cirrhosis.  J Hepatol. 1989;  8 107-114
  CrossrefPubMedGoogle Scholar
• 17 Clemmesen J O, Hoy C-E, Kondrup J et al. Splanchnic metabolism of fuel substrates in acute liver failure.  J Hepatol. 2000;  33 941-948
  CrossrefPubMedGoogle Scholar
• 18 Plauth M, Cabré E, Campillo B et al. ESPEN Guidelines Parenteral Nutrition. Liver Disease.  Clin Nutr. 2009;  28 436-444
  CrossrefPubMedGoogle Scholar
• 19 Clemmesen J O, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure.  Gastroenterology. 2000;  118 1131-1139
  CrossrefPubMedGoogle Scholar
• 20 Ballmer P E, Walshe D, McNurlan M A et al. Albumin synthesis rates incirrhosis: correlation with Child-Turcotte Classification.  Hepatology. 1993;  18 292-297
  CrossrefPubMedGoogle Scholar
• 21 Plauth M, Cabré E, Riggio O et al. DGEM: Plauth M, Ferenci P, Holm E et al. ESPEN Guidelines on Enteral Nutrition: Liver Disease.  Clin Nutr. 2006;  25 285-294
  CrossrefPubMedGoogle Scholar
• 22 Plank L D, McCall J L, Gane E J et al. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.  Clin Nutr. 2005;  24 288-296
  CrossrefPubMedGoogle Scholar
• 23 Cabré E, Rodriguez-Iglesias P, Caballeria J et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.  Hepatology. 2000;  32 36-42
  CrossrefPubMedGoogle Scholar
• 24 Kearns P J, Young H, Garcia G et al. Accelerated improvement of alcoholic liver disease with enteral nutrition.  Gastroenterology. 1992;  102 200-205
  PubMedGoogle Scholar
• 25 Morgan T R, Moritz T E, Mendenhall C L et al. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275.  J Am Coll Nutr. 1995;  14 152-158
  PubMedGoogle Scholar
• 26 Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management.  Lancet Neurol. 2007;  6 442-455
  CrossrefPubMedGoogle Scholar
• 27 Cabré E, González-Huix F, Abad A et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial.  Gastroenterology. 1990;  98 715-720
  PubMedGoogle Scholar
• 28 Plauth M, Schütz T, Buckendahl D P et al. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism.  J Hepatol. 2004;  40 228-233
  CrossrefPubMedGoogle Scholar
• 29 Le Cornu K A, McKiernan F J, Kapadia S A et al. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation.  Transplantation. 2000;  69 1364-1369
  CrossrefPubMedGoogle Scholar
• 30 Swart G R, Zillikens M C, van Vuure J K et al. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver.  Br Med J. 1989;  299 1202-1203
  CrossrefPubMedGoogle Scholar
• 31 Plank L D, Gane E J, Peng S et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.  Hepatology. 2008;  48 557-566
  CrossrefPubMedGoogle Scholar
• 32 Keohane P P, Attrill H, Grimble G et al. Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy.  J Parenter Enteral Nutr. 1983;  7 346-350
  CrossrefPubMedGoogle Scholar
• 33 Córdoba J, López-Hellín J, Planas M et al. Normal protein for episodic hepatic encephalopathy: results of a randomized trial.  J Hepatol. 2004;  41 38-43
  CrossrefPubMedGoogle Scholar
• 34 Horst D, Grace N D, Conn H O et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.  Hepatology. 1984;  4 279-287
  CrossrefPubMedGoogle Scholar
• 35 Marchesini G, Bianchi G, Merli M et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.  Gastroenterology. 2003;  124 1792-1801
  CrossrefPubMedGoogle Scholar
• 36 Muto Y, Sato S, Watanabe A et al. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis.  Clin Gastroenterol Hepatol. 2005;  3 705-713
  CrossrefPubMedGoogle Scholar
• 37 Marchesini G, Fabbri A, Bianchi G et al. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.  Hepatology. 1996;  23 1084-1092
  CrossrefPubMedGoogle Scholar
• 38 Druml W, Fischer M, Pidlich J et al. Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides.  Am J Clin Nutr. 1995;  61 812-817
  PubMedGoogle Scholar
• 39 Naylor C D, O’Rourke K, Detsky A S et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis.  Gastroenterology. 1989;  97 1033-1042
  PubMedGoogle Scholar
• 40 Als-Nielsen B, Koretz R L, Kjaergard L L et al. Branched-chain amino acids for hepatic encephalopathy.  Cochrane Database Syst Rev. 2003;  CD001939
  PubMedGoogle Scholar
• 41 Olde Damink S W, Dejong C H, Deutz N E et al. Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin molecule.  Med Hypotheses. 1999;  52 515-519
  CrossrefPubMedGoogle Scholar
• 42 Olde Damink S WM, Jalan R, Deutz N EP et al. Isoleucine infusion during „simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients.  Hepatology. 2007;  45 560-568
  CrossrefPubMedGoogle Scholar
• 43 Plank L D, Mathur S, Gane E J et al. Perioperative immunonutrition in liver transplantation: Results of a double-blind randomized controlled trial.  Clin Nutr Suppl. 2010;  5 (S 02) 3
  PubMedGoogle Scholar
• 44 Chin S E, Shepherd R W, Thomas B J et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement.  Am J Clin Nutr. 1992;  56 158-163
  PubMedGoogle Scholar

Prof. Dr. Mathias Plauth

Klinik für Innere Medizin
Städtisches Klinikum Dessau

Auenweg 38

06847 Dessau

Email: mathias.plauth@klinikum-dessau.de